Linked In       FaceBook       Twitter       You Tube
Project management using Podio




Michael Lewinski, PhD (Chair)
Roche Molecular Systems, Inc.            Email

Infectious Diseases Subdivision Leadership

Committee/Subdivision Purpose and Responsibilities

Infectious Diseases Links & Resources
Links to Infectious Diseases Related Websites
Rules and Regulations Affecting Clinical Laboratorians
HIV Sequence Database




Infectious Diseases Subdivision

Infectious Diseases Subdivision


The Infectious Diseases Subdivision is comprised of AMP members who indicate that they have a professional interest in infectious diseases. The Infectious Diseases Subdivision Leadership has membership on the Program, Nominating, and Training & Education Committees to ensure the continuing education and professional development of those who use molecular diagnostics in the diagnosis and management of infectious diseases. Recent projects, responsibilities and accomplishments include organizing a workgroup to discuss HSV testing. More information about the activities of the Infectious Diseases Subdivision can be found in the Subdivision Reports section of the AMP Newsletter.


Committee Participation

The Infectious Diseases Subdivision has representatives on the Clinical Practice, Nominating, Program, and Training & Education Committees.


Middle Eastern respiratory syndrome coronavirus (MERS-CoV) continues to spread in the Middle East and Europe, though as of June 18, CDC had not reported any cases in the U.S. FDA issued an Emergency Use Authorization (EUA) on June 5, 2013, to authorize use of CDC's novel coronavirus 2012 real-time RT-PCR assay to test for MERS-CoV in clinical respiratory, blood, and stool specimens. CDC will distribute the test to qualified laboratories at:


Updates, case definitions, and guidance for public health departments, healthcare providers and laboratories can be found on the CDC website at